Dental Implant Success Rates: What 40+ Clinical Studies Actually Show
A source-verified review of survival vs. success distinction, brand-specific long-term data, risk factors with quantified odds ratios, peri-implantitis prevalence, and how to critically evaluate implant studies before trusting a clinic's marketing claims.
What Does "Implant Success Rate" Actually Mean?
When clinics advertise "98% success rates," they are almost always reporting survival rates — not true success rates. These are fundamentally different metrics, and conflating them is the most common source of misleading implant statistics.
The implant is still physically present in the jaw — it has not been removed or lost due to failure. This is the most commonly reported metric. An implant can "survive" while still causing complications.
The implant is present and functioning without significant complications — no pain, no peri-implantitis, no mobility, no bone loss beyond defined thresholds. Always a lower number than survival rate.
Overall Implant Survival Over Time (1–20 Years)
Meta-analysis data pooled from large systematic reviews. Sources: PubMed 39305362 (20-year meta-analysis, 2024), PubMed 30904559 (10-year meta-analysis, 2019).
These figures represent weighted averages across implant brands and patient populations. Individual results vary based on the risk factors described below.
Sources: PubMed 39305362, PubMed 30904559. All data points represent pooled survival rates from systematic reviews and meta-analyses.
Key takeaway: Implants show a gradual decline in survival probability over time — from 99.3% at 1 year to 92% at 20 years. This decline is not linear: most failures occur in the first year (early failure, due to failed osseointegration) or after 10 years (late failure, typically due to peri-implantitis or mechanical complications). Years 1–10 are the most stable period.
Brand Comparison: Straumann vs. Nobel Biocare vs. Zirconia
Direct brand comparison based on published clinical evidence. Sample sizes and study designs vary — see notes column for important context on each data point.
Important: Several manufacturer-sponsored studies are included below. These are clearly marked. Manufacturer studies are not inherently invalid, but independent replication adds confidence.
| Brand | 10yr Survival | Sample Size | Study Type | Source |
|---|---|---|---|---|
| Straumann Switzerland, Tissue-Level |
98.2% | 4,591 implants multicenter |
Retrospective multicenter | PubMed 25134415 French et al., 2015 |
| Straumann SLA Sandblasted, Acid-Etched |
99.7% | 374 implants single-center |
Prospective, independent | PubMed 25370914 Roccuzzo et al., 2014 |
| Straumann Tissue-Level, 12–23yr |
88% | 216 implants long follow-up |
Retrospective, 12–23yr range | PubMed 25810237 Blanes et al., 2015 |
| Nobel Biocare Multiple systems |
95.1% | 12,803 implants 106 studies |
Manufacturer meta-analysis | Nobel Biocare Meta-Analysis |
| NobelActive Tapered design |
97.9% | Multi-center RCT data |
Manufacturer-sponsored RCT | Nobel Biocare Clinical Data |
| Zirconia (Ceramic) All ceramic systems |
95.1% | Pooled data systematic review |
Systematic review, 2024 | PubMed 39124755 2024 Systematic Review |
| Osstem South Korea |
~96% (3–5yr) | Growing evidence limited 10yr data |
Shorter follow-up studies | Multiple short-term RCTs; no independent 10yr mega-study yet |
Table compiled from peer-reviewed literature and manufacturer publications. "Manufacturer meta-analysis" entries should be interpreted with the caveat that publication bias may inflate reported rates. Always ask your surgeon which specific implant system and surface treatment they use.
Straumann Deep Dive: Multiple Studies Over Time
Straumann has the largest independent (non-manufacturer-sponsored) evidence base of any implant brand, making it possible to observe a realistic long-term trajectory. The pattern across studies tells a more nuanced story than any single headline number.
PubMed 25370914
PubMed 30110515
PubMed 25134415
PubMed 25810237
The drop from ~98% (10yr) to 88% (12–23yr range) is consistent with population-level attrition: older implants placed in the 1990s–early 2000s in less-controlled settings. Modern implant placement, surface technology, and follow-up protocols are expected to show better long-term results.
Straumann's SLA (Sandblasted, Large-grit, Acid-etched) surface is independently associated with faster and more reliable osseointegration. The 99.7% 10-year result in Roccuzzo et al. (PubMed 25370914) is the strongest 10-year data point for any single implant design across independent studies.
The Blanes et al. study (PubMed 25810237) followed implants placed between 1982–1995, with follow-up extending 12–23 years. This patient cohort pre-dates modern surface treatment, bone augmentation techniques, and digital planning. It is likely a pessimistic estimate for implants placed today.
Risk Factors That Affect Implant Success
The following risk factors are supported by quantified evidence — odds ratios and risk multipliers from peer-reviewed meta-analyses and systematic reviews.
Important: most risk factors are modifiable or manageable. Presence of a risk factor does not mean implants are impossible — it means informed discussion with your surgeon is essential.
| Risk Factor | Quantified Risk | Modifiable? | Recommendation | Source |
|---|---|---|---|---|
| Smoking (any amount) |
OR 2.4–2.6x failure risk | Yes | Quit 1–2 weeks before surgery, 8 weeks after. Heavy smokers (20+/day) face up to 4x risk. | PubMed 31955453 J Clin Perio 2020 |
| Diabetes (uncontrolled, HbA1c >8%) |
OR 1.777 failure risk | Yes (control it) | Achieve HbA1c <7% before surgery. Controlled diabetics show comparable outcomes to non-diabetics. | PubMed 39867008 Cureus 2025 |
| Bisphosphonate medications (Alendronate, Zoledronic acid) |
0.13% BRONJ risk | Partially | Low absolute risk. Discuss drug holiday with prescribing physician. IV bisphosphonates carry higher risk than oral forms. | NCBI Books AAOMS Guidelines |
| Anticoagulants / Blood thinners (Warfarin, NOACs) |
Bleeding risk, not failure | Manageable | Do not stop independently. Surgeon coordinates with cardiologist for peri-operative management. Most patients can safely receive implants. | Clinical consensus guidelines |
| Titanium sensitivity (rare hypersensitivity) |
~0.6% prevalence | Switch to zirconia | Patch testing available. Zirconia implants provide a clinically equivalent alternative with comparable success rates. | PubMed 18705814 Contact Derm 2008 |
| Poor bone density / quality (Type IV bone, atrophy) |
Higher early failure risk | Yes (bone graft) | Bone augmentation (grafting, sinus lift) resolves most volume deficiencies. Requires 3–9 months of additional healing time before implant placement. | PMC3425398 Ridge preservation 2012 |
| Poor oral hygiene (ongoing, post-placement) |
Primary peri-implantitis driver | Yes | Professional cleaning every 6 months. Interdental brushes daily around implant crowns. Peri-implantitis is the leading cause of late implant failure. | PMC9583568 Prevalence study 2022 |
| Under 18 years old (jaw still growing) |
Implant will not track jaw growth | Wait | Implants placed before jaw growth completion will appear submerged as the jaw continues to develop. Wait until skeletal maturity (typically 17–20 years old). | Clinical consensus |
OR = Odds Ratio. BRONJ = Bisphosphonate-Related Osteonecrosis of the Jaw. All figures from peer-reviewed publications. This table is educational — always discuss your specific risk profile with a qualified implantologist.
Peri-Implantitis — The Real Long-Term Risk
Peri-implantitis is the most clinically significant long-term complication of dental implants — and the one most commonly omitted from clinic marketing materials. Understanding it is essential for any informed implant decision.
Mucositis vs. Peri-Implantitis: Understanding the Spectrum
- Inflammation of soft tissue only
- No bone loss
- Analogous to gingivitis
- Fully reversible with treatment
- Affects ~46% over 20 years
- Treated with professional cleaning
- Inflammation + bone loss
- Analogous to periodontitis
- Not self-resolving
- Requires professional intervention
- Affects ~19.5% of patients
- Treatable — rarely leads to loss if caught early
Risk Factors for Peri-Implantitis
- History of periodontitis — the single strongest predictor of peri-implantitis risk
- Smoking — compromises blood supply and immune response in gingival tissue
- Poor oral hygiene — biofilm accumulation at implant-gum junction is the primary trigger
- Diabetes — impaired immune response increases susceptibility to bacterial infection
- Implant surface properties — rougher surfaces may accumulate more biofilm supracrestally
- Implant positioning — suboptimal placement makes cleaning difficult
How to Prevent Peri-Implantitis
Implant-specific instruments remove biofilm from peri-implant sulcus that toothbrushes cannot reach.
Standard floss can tear around implant crowns. Interdental brushes are more effective for implant margins.
Placing implants in a mouth with active periodontal disease is a known risk factor. Get the periodontitis under control first.
Bleeding around the implant, swelling, or sensitivity are not normal long-term. See a dentist promptly — mucositis is reversible; established peri-implantitis is not.
Source: PMC9583568 — Derks et al., prospective data from Swedish population cohort. Note: prevalence figures vary across studies and populations (6–56% range). The 19.5% patient-level figure is from this specific longitudinal study and is widely cited in systematic reviews.
Other Complications: Nerve Injury, Bone Loss, and Surgical Risks
Beyond peri-implantitis, the following complications are documented in the literature. Each is rare when proper protocols are followed — but patients should be aware of them before consenting to surgery.
Inferior Alveolar Nerve Injury
0% at >2mm safety marginThe inferior alveolar nerve runs through the mandible (lower jaw) and can potentially be damaged during lower jaw implant placement. A systematic review (PMC12221155) confirmed that maintaining a minimum 2mm safety margin between the implant apex and the nerve canal effectively eliminates this risk.
Post-Extraction Bone Loss
29–63% volume loss (6 months)After a tooth is extracted, the surrounding alveolar bone begins resorbing immediately. A landmark study (PMC3425398) documented 29–63% of bone width can be lost within the first 6 months of extraction — findings that have been reconfirmed in 2025 ridge preservation research. This is why immediate or early implant placement is often recommended when bone quality allows, and why delayed cases frequently require bone grafting.
Sinus Membrane Perforation
0.5–3% in sinus lift casesOccurs during sinus lift augmentation procedures in the upper back jaw. Small perforations can often be repaired intraoperatively. The sinus lift procedure itself — though adding complexity — has a well-documented safety and success record. Intraoperative CBCT guidance significantly reduces this risk in experienced hands.
On BDA and national survey data: Some published complication rates (including from British Dental Association surveys) reflect self-reported clinician data, which may undercount complications due to reporting bias and patient follow-up drop-off. Prospective studies with defined follow-up protocols generally produce more reliable complication estimates.
Titanium vs. Zirconia Implants: What the Data Shows
Zirconia (ceramic) implants have grown in popularity among patients seeking metal-free options. Here is what the clinical evidence actually shows — without the marketing language.
| Property | Titanium | Zirconia (Ceramic) |
|---|---|---|
| Osseointegration | Well-documented — gold standard since 1960s | No significant difference — confirmed by PubMed 39124755 (2024 systematic review) |
| 10-year survival | 95.1–99.7% (multiple large studies) | ~95.1% (systematic review pooled data) |
| Long-term data (>15yr) | Extensive — decades of follow-up | Limited — zirconia implants introduced ~2010s |
| Metal allergy concern | 0.6% titanium sensitivity (PubMed 18705814) | No metal — option for confirmed Ti sensitivity |
| Aesthetics | Grey metal visible if gum recedes | White ceramic — no discolouration if gum recedes |
| Fracture resistance | Highly ductile — bends before breaking | Brittle — can fracture under lateral load; one-piece design limits angulation options |
| Cost in Antalya | 400–1,300 EUR per implant + crown | 800–1,800 EUR per implant + crown |
Bottom line: A 2024 systematic review (PubMed 39124755) found no statistically significant difference in osseointegration or short-to-medium-term survival rates between titanium and zirconia implants. Zirconia is a clinically valid choice — particularly for patients with confirmed titanium sensitivity or high aesthetic demands. However, titanium has 60+ years of follow-up data, while zirconia has approximately 10–15 years. Patients choosing zirconia should understand they are accepting a smaller long-term evidence base.
How to Interpret Dental Implant Study Data
Not all implant success rate claims are equally reliable. Here are the most important caveats to apply when evaluating any statistic — whether from a clinic brochure, a manufacturer website, or a scientific paper.
As explained above: survival means "still there," success means "still there with no significant complications." A clinic quoting "98% success" when they mean survival is not technically lying — but they are presenting the more favorable number.
This is well-documented in the implant literature. Publication bias (negative results less likely to be published), controlled patient selection in manufacturer trials, and investigator financial relationships all contribute. The Nobel Biocare meta-analysis (95.1% at 10yr) was funded by Nobel Biocare — this doesn't invalidate it, but independent replication is more robust. Straumann's best independent data (Roccuzzo et al., PubMed 25370914) is from a non-funded academic group, which is why the 99.7% figure carries more weight.
Controlled prospective studies select low-risk patients (non-smokers, no systemic disease, good bone). Real-world clinical practice includes higher-risk patients and less controlled follow-up. Expect real-world outcomes to be slightly lower than published trial figures — which is why population-level meta-analyses are more useful than single-center controlled trials.
If 30% of study participants are lost to follow-up by year 10, the survival rate is calculated only on those who returned — who may be disproportionately the patients with successful outcomes. High dropout studies report higher survival rates. Look for studies that report their dropout rates explicitly and use survival analysis methods (Kaplan-Meier) to account for censored data.
Prospective studies follow patients forward from the time of implant placement with pre-defined follow-up checkpoints and outcome measures — stronger evidence. Retrospective studies review historical records — useful for large sample sizes but subject to incomplete data and recall bias. The strongest implant evidence comes from prospective multi-center studies with pre-specified success criteria.
Our approach on this page: We have cited primary PubMed sources with study sizes and design type for every major data point. Where manufacturer data is cited, it is labeled as such. Where estimates are extrapolated rather than directly measured, they are marked with "~" or "estimated." We observe what studies show — we do not claim causal relationships without experimental evidence.
Frequently Asked Questions
The most common questions about dental implant success rates — answered with reference to the clinical evidence on this page.
Based on a 2019 meta-analysis of 10-year data (PubMed 30904559), the pooled implant survival rate at 10 years is approximately 95.1%. For premium brands, rates are higher: Straumann tissue-level implants show 98.2% in a study of 1,692 implants (PubMed 30110515), while the Straumann SLA surface shows 99.7% in an independent 374-implant study (PubMed 25370914). Keep in mind: these are survival rates, not success rates — success rates accounting for all complications would be lower.
A 2024 meta-analysis (PubMed 39305362) found that approximately 92% of implants survive beyond 20 years — which is genuinely excellent for any medical device. The titanium screw itself can theoretically last a lifetime, as titanium is biologically inert and does not degrade in the body. The ceramic crown on top typically needs replacement after 10–15 years due to normal wear. "Lifetime" claims are plausible — but apply to ideal conditions with good oral hygiene and regular dental care.
Yes — this is one of the best-documented risk factors in implant dentistry. A meta-analysis of 292 studies (PubMed 31955453, J Clin Periodontol 2020) found that smokers have a 2.4–2.6x higher odds ratio for implant failure compared to non-smokers. Heavy smokers (20+ cigarettes/day) face up to 4x the risk. Quitting smoking before surgery is one of the highest-impact modifiable risk reductions available. Clinicians recommend cessation at least 1–2 weeks before surgery and 8 weeks after implant placement for osseointegration to proceed normally.
Peri-implantitis is bacterial inflammation of the tissue and bone surrounding an implant, analogous to periodontitis around natural teeth. A large prospective Swedish study (PMC9583568) found it affects approximately 19.5% of patients over time, with peri-implant mucositis (the earlier, softer-tissue stage) found in 46% of patients over 20 years. The critical point: peri-implantitis does not automatically mean implant loss. Caught and treated early, implants can be retained. The primary prevention is professional cleaning every 6 months and daily interdental cleaning around implant crowns.
A 2024 systematic review (PubMed 39124755) found no statistically significant difference in osseointegration or short-to-medium-term survival rates between titanium and zirconia (ceramic) implants. Zirconia shows approximately 95.1% survival at 10 years in pooled data. The key difference is not current survival rate — it is the evidence base. Titanium has 60+ years of follow-up data across millions of patients. Zirconia has approximately 10–15 years. Both are clinically valid — zirconia is the better choice for patients with confirmed titanium sensitivity or very high aesthetic requirements, where the gum margin is visible and metal discolouration would be a concern.
Straumann has the strongest independent (non-manufacturer-funded) long-term evidence base. Independent studies show 98.2% survival at 10 years across 4,591 implants (PubMed 25134415) and 99.7% for SLA-surface implants at 10 years in 374 implants (PubMed 25370914). Nobel Biocare reports 95.1% across 12,803 implants, though this is from a manufacturer-sponsored meta-analysis. That said: no head-to-head randomized trial comparing all major brands exists. The surgeon's experience, patient selection, and post-operative care contribute as much to outcomes as the brand. Avoid clinics that cannot tell you exactly which implant system and surface type they use.
Sources & References
All data points on this page are traceable to peer-reviewed publications or official manufacturer documentation. Last verified March 2026.
Continue your research or get a free consultation